You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

Litigation Details for GREE, INC v. SUPERCELL OY (E.D. Tex. 2019)

✉ Email this page to a colleague

« Back to Dashboard

GREE, INC v. SUPERCELL OY (E.D. Tex. 2019)

Docket	⤷ Try a Trial	Date Filed	2019-02-27
Court	District Court, E.D. Texas	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	James Rodney Gilstrap
Jury Demand	Plaintiff	Referred To
Patents	10,001,469; 10,005,783; 10,028,910; 10,034,873; 10,035,766; 10,040,783; 10,040,859; 10,064,856; 10,064,875; 10,064,901; 10,064,911; 10,073,873; 10,098,910; 10,105,415; 10,105,418; 10,106,546; 10,115,318; 10,117,774; 10,126,299; 10,172,516; 10,172,856; 10,172,861; 10,172,875; 10,342,771; 10,342,859; 10,342,875; 6,019,980; 6,027,469; 6,053,828; 6,080,913; 6,168,016; 6,368,856; 6,469,030; 6,572,873; 6,574,971; 6,616,771; 6,758,771; 6,872,156; 6,875,137; 6,956,027; 6,985,771; 7,056,655; 7,060,875; 7,101,574; 7,137,913; 7,140,988; 7,172,751; 7,342,117; 7,415,858; 7,572,783; 7,604,795; 7,655,038; 7,700,299; 7,700,561; 7,700,775; 7,754,861; 7,775,911; 7,858,070; 7,858,789; 7,872,049; 7,872,050; 7,875,342; 7,910,131; 7,910,758; 7,956,037; 7,956,049; 7,956,067; 7,985,418; 7,985,540; 8,017,980; 8,029,783; 8,038,988; 8,058,418; 8,071,795; 8,158,616; 8,288,116; 8,288,165; 8,288,320; 8,299,106; 8,318,750; 8,318,758; 8,388,971; 8,388,985; 8,415,342; 8,481,055; 8,481,064; 8,481,067; 8,540,967; 8,561,859; 8,574,102; 8,574,856; 8,574,858; 8,604,014; 8,604,057; 8,754,011; 8,754,045; 8,754,065; 8,754,070; 8,754,078; 8,754,090; 8,754,096; 8,754,106; 8,754,108; 8,754,109; 8,754,131; 8,771,758; 8,771,956; 8,795,107; 8,795,108; 8,795,725; 8,828,956; 8,859,023; 8,859,509; 8,859,572; 8,859,795; 8,901,299; 8,956,288; 8,980,901; 9,023,783; 9,033,828; 9,066,856; 9,066,980; 9,073,858; 9,073,988; 9,096,861; 9,101,540; 9,101,669; 9,107,898; 9,156,859; 9,320,750; 9,358,215; 9,415,098; 9,415,102; 9,561,066; 9,561,068; 9,561,080; 9,561,175; 9,561,288; 9,561,331; 9,572,856; 9,572,861; 9,604,113; 9,604,901; 9,616,049; 9,616,059; 9,616,061; 9,616,066; 9,616,096; 9,616,105; 9,616,126; 9,616,137; 9,655,956; 9,655,979; 9,669,096; 9,669,106; 9,669,107; 9,669,108; 9,700,561; 9,700,775; 9,751,859; 9,757,418; 9,758,561; 9,758,789; 9,771,358; 9,771,418; 9,775,913; 9,789,057; 9,789,062; 9,789,064; 9,789,078; 9,789,108; 9,789,156; 9,789,165; 9,795,604; 9,828,415; 9,856,320; 9,861,757; 9,861,771; 9,872,862; 9,901,113; 9,910,046; 9,913,901; 9,913,910; 9,956,172; 9,980,910
Link to Docket	External link to docket

Small Molecule Drugs cited in GREE, INC v. SUPERCELL OY

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Biologic Drugs cited in GREE, INC v. SUPERCELL OY

The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .

Details for GREE, INC v. SUPERCELL OY (E.D. Tex. 2019)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2020-05-11	175	Memorandum & Opinion	position: ’655 Patent, at [57] Abstract, col.2 ll.27–32, col.4 ll.24–27, col.9 l.64 – col.10 l.5, col.13 …481 Patent”). In the ’172 Case, Plaintiff asserts U.S. Patent No. 10,286,302 (the “’302 Patent”). … field • ’481 Patent Claim 4 • ’137 Patent Claims 8, 10, 13 Having reviewed…infringement of five U.S. Patents. In the ’070 Case, Plaintiff asserts four U.S. Patents: No. 9,604,137…position: ’873 Patent col.1 ll.24–32, col.4 ll.19–24, col.4 ll.29–32, col.5 ll.29–41, col.5 ll.47– 51	External link to document
2020-05-20	181	~Util - Terminate Motions AND Memorandum & Opinion	knowledge. Brazos River Auth. v. GE Ionics, Inc., 469 F.3d 416, 433 (5th Cir. 2006) (“Thus, a rule 30(b…and Supercell based in Finland. Contending its patents were being infringed, GREE filed several suits… products that allegedly practice the asserted patents. Id. at 4–5; see also Dkt. No. 156 at 4. Second…February 2019 2:19-cv-00070-JRG-RSP Patent Plaintiff District Court, E.D. Texas…portions of GREE’s source code. Dkt. No. 152 at 8–10. In its Motion to Compel, Supercell largely	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.